Search
Madrigal Pharmaceuticals Inc
MDGLAdd to Watchlist
512.650USD
0.0000.00%
Close 06/26, 16:00（ET）Quotes delayed by 15 min
11.81BMarket Cap
LossP/E TTM
Madrigal Pharmaceuticals Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
958.40M
432.05%
EPS(YoY)
-12.85
41.33%
Analyst Rating
BUY
2026-06-27
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Madrigal Pharmaceuticals Inc?
According to Madrigal Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 958.40M, with a year-on-year change of 432.05.
What are the current assets of Madrigal Pharmaceuticals Inc?
According to Madrigal Pharmaceuticals Inc's FY2025 earnings report, its current assets were 1.25B, with a year-on-year change of 20.61.
What are the total assets of Madrigal Pharmaceuticals Inc?
According to Madrigal Pharmaceuticals Inc's FY2025 earnings report, its total assets of Madrigal Pharmaceuticals Inc were 1.26B, with a year-on-year change of 20.85.
What are the total liabilities of Madrigal Pharmaceuticals Inc?
According to Madrigal Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Madrigal Pharmaceuticals Inc were 656.90M, with a year-on-year change of 128.20.
What is the total equity of Madrigal Pharmaceuticals Inc?
According to Madrigal Pharmaceuticals Inc's FY2025 earnings report, its total equity of Madrigal Pharmaceuticals Inc was 602.69M, with a year-on-year change of -20.11.
What is the net investment of Madrigal Pharmaceuticals Inc?
According to Madrigal Pharmaceuticals Inc's FY2025 earnings report, its net investment of Madrigal Pharmaceuticals Inc was 32.32M, with a year-on-year change of 111.78.
What is the net financing of Madrigal Pharmaceuticals Inc?
According to Madrigal Pharmaceuticals Inc's FY2025 earnings report, its net financing of Madrigal Pharmaceuticals Inc was 255.98M, with a year-on-year change of -65.18.
What is the Earnings Per Share (EPS) of Madrigal Pharmaceuticals Inc?
According to Madrigal Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -12.85, with a year-on-year change of 41.33.
What is the net margin of Madrigal Pharmaceuticals Inc?
According to Madrigal Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was -30.08, with a year-on-year change of 88.37.
What is the gross margin of Madrigal Pharmaceuticals Inc?
According to Madrigal Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 94.14, with a year-on-year change of -2.48.
What is the debt-to-asset ratio of Madrigal Pharmaceuticals Inc?
According to Madrigal Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 26.98, with a year-on-year change of 139.21.
What is the Return on Equity (ROE) of Madrigal Pharmaceuticals Inc?
According to Madrigal Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -42.49, with a year-on-year change of 47.12.
What is the Return on Assets (ROA) of Madrigal Pharmaceuticals Inc?
According to Madrigal Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -25.05, with a year-on-year change of 54.76.
What is the operating profit of Madrigal Pharmaceuticals Inc?
According to Madrigal Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -300.10M, with a year-on-year change of 39.72.
